© 2020 – 2023 AEA3 WEB | AEAƎ United Kingdom News
AEA3 WEB | AEAƎ United Kingdom News
News

New AI test can predict which men will benefit from prostate cancer drug

Artificial intelligence tool determines best candidates to take abiraterone, which can halve risk of death from disease

Doctors have developed an artificial intelligence tool that can predict which men with prostate cancer will benefit from a drug that halves the risk of dying.

Abiraterone has been described as a “gamechanger” treatment for the disease, which is the most common form of cancer in men in more than 100 countries. It has already helped hundreds of thousands with advanced prostate cancer to live longer.

Continue reading…

Related posts

Russia-Ukraine war: Zelenskiy hails ‘powerful blows’ by Ukrainian army as Russia hints at scaling back offensive – live

AEA3

Truss-favoured thinktank attacks ‘massive transfer of wealth’ to landowners

AEA3

Russia-Ukraine war: Nato head says war could last years; Ukraine governor reports ‘tough battles’ near Sievierodonetsk – live

AEA3

Pin It on Pinterest

Share This